Grove Bank & Trust Eli Lilly & CO Transaction History

Grove Bank & Trust

$593 Million
Q1 2024

A detailed history of Grove Bank & Trust transactions in Eli Lilly & CO stock. As of the latest transaction made, Grove Bank & Trust holds 5,804 shares of LLY stock, worth $5.45 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

5,804

Previous 5,732 1.26%

Holding current value

$5.45 Million

Previous $3.34 Million 35.14%

% of portfolio

0.76%

Previous 0.62%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $42,638 - $57,044	72 Added 1.26%	5,804 $4.52 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $50,418 - $59,436	96 Added 1.7%	5,732 $3.34 Million
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $222,131 - $306,242	511 Added 9.97%	5,636 $3.03 Million
Q2 2023 Jul 27, 2023	SELL	$350.74 - $468.98 $7,365 - $9,848	-21 Reduced 0.41%	5,125 $2.4 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $317,463 - $372,846	-1,022 Reduced 16.57%	5,146 $1.77 Million

Q4 2022 Feb 03, 2023	SELL	$321.55 - $374.67 $363,673 - $423,751	-1,131 Reduced 15.5%	6,168 $2.26 Million
Q3 2022 Oct 28, 2022	BUY	$296.48 - $337.87 $29,648 - $33,787	100 Added 1.39%	7,299 $2.36 Million
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $13,657 - $16,036	49 Added 0.69%	7,199 $2.33 Million
Q1 2022 Apr 22, 2022	BUY	$234.69 - $291.66 $49,050 - $60,956	209 Added 3.01%	7,150 $2.05 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $41,372 - $51,343	184 Added 2.72%	6,941 $1.92 Million
Q3 2021 Oct 28, 2021	BUY	$221.6 - $272.71 $29,472 - $36,270	133 Added 2.01%	6,757 $1.56 Million
Q2 2021 Jul 28, 2021	SELL	$180.55 - $233.54 $2,527 - $3,269	-14 Reduced 0.21%	6,624 $1.52 Million
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $2,136 - $2,765	-13 Reduced 0.2%	6,638 $1.24 Million
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $57,663 - $76,302	442 Added 7.12%	6,651 $1.12 Million
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $11,551 - $13,361	-79 Reduced 1.26%	6,209 $919,000
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $24,692 - $29,716	181 Added 2.96%	6,288 $1.03 Million
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $29,762 - $36,837	-250 Reduced 3.93%	6,107 $847,000
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $9,622 - $11,918	-90 Reduced 1.4%	6,357 $835,000
Q3 2019 Oct 30, 2019	BUY	$106.79 - $116.16 $76,034 - $82,705	712 Added 12.41%	6,447 $721,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $1,772 - $2,069	-16 Reduced 0.28%	5,735 $635,000
Q1 2019 Apr 26, 2019	BUY	$111.31 - $131.02 $4,341 - $5,109	39 Added 0.68%	5,751 $747,000
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $28,275 - $31,676	267 Added 4.9%	5,712 $661,000
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $1,202 - $1,502	-14 Reduced 0.26%	5,445 $584,000
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $23,467 - $26,932	-310 Reduced 5.37%	5,459 $466,000
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $11,873 - $14,016	-160 Reduced 2.7%	5,769 $446,000
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $29,170 - $31,288	-356 Reduced 5.66%	5,929 $501,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $484,384 - $537,618	6,285	6,285 $538,000

Others Institutions Holding LLY

# of Institutions

3,728

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $893B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account